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Abstract
Knowledge of pneumococcal lineages, their geographic distribution and antibiotic resistance patterns, can give insights into 
global pneumococcal disease. We provide interactive bioinformatic outputs to explore such topics, aiming to increase dissemi-
nation of genomic insights to the wider community, without the need for specialist training. We prepared 12 country- specific 
phylogenetic snapshots, and international phylogenetic snapshots of 73 common Global Pneumococcal Sequence Clusters 
(GPSCs) previously defined using PopPUNK, and present them in Microreact. Gene presence and absence defined using Roary, 
and recombination profiles derived from Gubbins are presented in Phandango for each GPSC. Temporal phylogenetic signal 
was assessed for each GPSC using BactDating. We provide examples of how such resources can be used. In our example use of 
a country- specific phylogenetic snapshot we determined that serotype 14 was observed in nine unrelated genetic backgrounds 
in South Africa. The international phylogenetic snapshot of GPSC9, in which most serotype 14 isolates from South Africa 
were observed, highlights that there were three independent sub- clusters represented by South African serotype 14 isolates. 
We estimated from the GPSC9- dated tree that the sub- clusters were each established in South Africa during the 1980s. We 
show how recombination plots allowed the identification of a 20 kb recombination spanning the capsular polysaccharide locus 
within GPSC97. This was consistent with a switch from serotype 6A to 19A estimated to have occured in the 1990s from the 
GPSC97- dated tree. Plots of gene presence/absence of resistance genes (tet, erm, cat) across the GPSC23 phylogeny were 
consistent with acquisition of a composite transposon. We estimated from the GPSC23- dated tree that the acquisition occurred 
between 1953 and 1975. Finally, we demonstrate the assignment of GPSC31 to 17 externally generated pneumococcal serotype 
1 assemblies from Utah via Pathogenwatch. Most of the Utah isolates clustered within GPSC31 in a USA- specific clade with the 
most recent common ancestor estimated between 1958 and 1981. The resources we have provided can be used to explore to 
data, test hypothesis and generate new hypotheses. The accessible assignment of GPSCs allows others to contextualize their 
own collections beyond the data presented here.
Data SUmmaRy
The following resources are accessible via www. pneumogen. 
net/ gps and Figshare, all links are documented in the Supple-
mentary Material (available Fig. S1 in the online version 
of this article). Input and output files, and scripts used to 
run BactDating on the GPSC phylogenies are available on 
Figshare. Roary output files from the 13 454 genomes are 
available on Figshare. Visualizations of gene presence and 
absence and distribution of recombination blocks across the 
genome for each GPSC are hosted on Phandango, with the 
input files available on the Phandango Github [1]. Phylo-
genetic snapshots are available for each of the 12 countries 
with >100 isolates, paired with metadata, can be interac-
tively viewed in Microreact (links in the Supplementary 
Material) [2]. Geographical distribution and other metadata 
can be interactively viewed in Microreact for each of the 73 
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common GPSCs (links in the Supplementary Material) [2]. 
GPSC alignments with recombination masked are available 
on Figshare. Raw fastq data, assemblies and annotations for 
13 454 pneumococcal genomes were previously released [3] to 
the European Nucleotide Archive (ENA) as part of the Global 
Pneumococcal Sequencing project (GPS) with metadata and 
accessions in the Supplementary Material (Fig. S1). Raw fastq 
data and assemblies for pneumococcal isolates from Utah 
have been deposited in the ENA under the study accession 
PRJEB34550 and individual accessions are in the Supplemen-
tary Material (Fig. S1). The authors confirm all supporting 
data, code and protocols have been provided within the article 
or through Supplementary Material files.
IntRODUCtIOn
Bacterial typing at the subspecies level to determine the 
lineage to which a pathogen belongs and distinguish it from 
others, is an important activity in the study and surveil-
lance of infectious disease. Characteristics such as resist-
ance, geographical spread and association with disease are 
key features of interest. Understanding their prevalence 
and distribution across lineages is informative for under-
standing the role of population structure in pneumococcal 
disease epidemiology. With the advent of high throughput 
sequencing, nucleotide variation across the whole genome 
can be used to cluster genetically related isolates into lineages, 
which are then a starting point for more detailed analysis. 
We previously published a genome- derived definition of 
Significance as a BioResource to the community
Analysis of the DNA of bacteria, such as the pneumo-
coccus, can provide important insights into how they 
cause disease. Whole- genome sequencing is increasingly 
cost effective to comprehensively type bacteria, though 
the analyses of such datasets often require specialist 
training. We have taken the results of our analyses and 
visualize them in an interactive online format to make 
the results and interpretation more accessible. Any new 
pneumococcal genome can be easily assigned to Global 
Pneumococcal Sequence Clusters using PopPUNK with 
the GPS database, or via Pathogenwatch. Furthermore, 
we provide international descriptions of GPSC recom-
bination profiles, gene content, estimated age of emer-
gence and population snapshots of geographical regions 
to provide even greater context. Providing such bioinfor-
matic output in interactive format makes data exploration 
easier, allowing dissemination of genomic insights into 
the wider community, and can be used as teaching tools. 
These resources could also facilitate cross- disciplinary 
research beyond the original aims of the project, for 
example mathematical modelling of resistance, serotype 
switching or geographical spread.
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pneumococcal lineages based on an international collection 
of ~20 000 pneumococcal genomes using PopPUNK [3, 4].
The uptake and incorporation of DNA from the environment 
into the chromosome via transformation and homologous 
recombination are known to contribute more nucleotide vari-
ation than mutation in the pneumococcus [5]. The capacity 
for recombination varies between lineages and recombina-
tion events are unevenly distributed across the genome, with 
known hotspots in regions under high selection pressure such 
as the penicillin- binding proteins and the capsular polysac-
charide locus [6–8]. Recombination events can be detected 
and recombination rates quantified, which can be visualized 
across the genome to further explore recombination dynamics 
[1, 9]. As well as being biologically interesting, recombination 
obscures the true phylogenetic signal of vertical descent and 
is important to account for. Identifying recombination using 
blocks of dense SNPs lends itself to groups of closely related 
strains, and therefore relies on robust definitions of lineages.
Recombination can introduce new alleles or new genes into 
the chromosome. The latter contributes to the pneumococcal 
pangenome: the complete complement of genes observed in 
the species. The pangenome is made up of a core set of genes 
found in all isolates and accessory genes, including some that 
confer antibiotic resistance, that are variably present across 
the species. The frequencies of individual accessory genes are 
suggested to be in an equilibrium that is key in determining 
population structure [10–12].
The pneumococcal population structure, specifically the line-
ages observed and the extent to which they are established 
is known to vary between geographic locations. This is a 
constraint on local population restructuring after the introduc-
tion of pneumococcal conjugate vaccines (PCVs) [3, 11–13]. 
Comparisons of the presence/absence and prevalence of line-
ages between countries is also facilitated by the international 
definition of GPSCs as opposed to dataset- specific designa-
tions. Identifying features of the population structure unique 
to a geographical location and then contextualizing them in 
the relevant GPSC gives an international perspective. It can 
give insight into the acquisition and geographical spread of a 
resistance determinant, the introduction of a lineage into one 
country from another, and serotype switch or loss of capsule 
observed in one location.
Dating events in the pneumococcal population structure such 
as the migration of a lineage or the acquisition of a clini-
cally relevant feature is often useful. After the introduction 
of PCVs, some lineages were observed to shift from a vaccine 
serotypes to non- vaccine serotypes. Identifying the recom-
bination events that result in serotype switch and dating it 
has often revealed that the recombination event and serotype 
variant was established before vaccine implementation and 
was subsequently selected [3, 14, 15].
Here we provide population snapshots of 12 countries repre-
senting four continents in Microreact [2] annotated with 
the GPSCs and clinically relevant metadata. We additionally 
provide the lineage snapshots and recombination and gene 
presence/absence profiles for 73 common GPSCs interactively 
in Phandango [1]. We also provide dated GPSC phylogenies 
to allow the date of genomic events or geographical introduc-
tions to be determined. We present examples of how these 
resources can be used to answer topical pneumococcal ques-
tions, with preliminary interpretation, and demonstrate how 
external data can be assigned to GPSC using Pathogenwatch 
to aid comparisons between datasets.
mEthODS
DNA extraction and sequencing were described previously 
[3]. Briefly 13 454 pneumococcal isolates drawn from pneu-
mococcal disease surveillance programs and/or carriage 
studies in 30 countries were sequenced on an Illumina HiSeq 
platform and assembled and annotated as part of the Global 
Pneumococcal Sequencing project (GPS) [3, 16]. Isolates 
were clustered into lineages named Global Pneumococcal 
Sequence Clusters (GPSCs) using assemblies as input for 
PopPUNK [4]. Serotype, sequence type (ST) and antibiotic 
susceptibility were previously derived from the genomes [3]. 
The 13 454 assemblies annotated using Prokka were used 
as input for Roary with default minimum 95 % percentage 
identity for blastp, with and without splitting paralogues, 
with the former presented in Phandango [17, 18].
International GPSC snapshots
Lineage analyses were performed on 73 common GPSCs, 
representing 782 down to 22 isolates (Supplementary Mate-
rial). Illumina reads from each isolate were mapped against 
previously prepared references for each lineage [3, 19]. In brief, 
where a public closed reference did not exist a high- quality 
illumina draft assembly was reordered against a complete S. 
pneumoniae genome ATCC 700669 [3], the reference genome 
accession numbers are provided in the Supplementary Mate-
rial. The resulting alignment was used as input for Gubbins 
to identify recombination blocks and create recombination 
free phylogenies with RAxML [9, 20].
Dating
Taxa dates were recorded in years and the month converted 
to decimal, in the absence of month data the mid- year value 
of 0.5 was added. We assessed any temporal signal using the 
recombination- free phylogenies. BactDating was used to 
date 73 common GPSCs using the output of Gubbins [21]. 
We ran the BactDating R package with three replicates and 
one with randomized tip date through MCMC chains of 
100 000 000 generations sampled every 100 000 states with a 
10 000 000 burn- in using the mixed gamma model [21]. The 
three replicate MCMC chains were deemed to have converged 
with Gelman diagnostic of approximately 1 for mu, sigma 
and alpha using the coda R package [22]. We then assessed 
temporal signal by comparing the first replicate model to a 
model ran under the same parameters but with randomiza-
tion of the isolate dates with the modelcompare function of 
the BactDating package [21]. Finally, we assessed whether 
the effective sample size (ESS) on the first replicate model 
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Table 1. Population snapshots
Country No. of isolates Percentage 
IPD
Sampling years
South Africa 4615 63 % 1991, 2005–2014
The Gambia 1647 24 % 1993,1996–2014
USA 1584 100 % 1998–2009
Malawi 1304 43 % 1997–2015
Israel 1143 100 % 2005–2014
Peru 607 31 % 2006–2011
China 504 42 % 1995–2001, 2009–2017
Brazil 420 97 % 2008–2009, 2012–2013
Nepal 416 16 % 2005–2009, 2011–2014
Poland 189 100 % 2007–2013
Mozambique 167 100 % 2008–2010
India 114 97 % 2007–2010, 2013–2016
IPD, Invasive Pneumococcal Disease.
was greater than 200 using the effectiveSize function of the 
coda R package [22].
As a comparison to BactDating, we additionally ran Bayesian 
evolutionary analysis software beast v2.4.1 on the four sub- 
clades of GPSC3 [23]. We ran three replicate MCMC chains of 
100 000 000 generations, with a 10 000 000 burn- in, that were 
sampled every 1000 states with the discrete gamma model 
of heterogeneity among sites, the relaxed clock model of 
nucleotide substitution with the Bayesian skyline tree prior. 
ESS were greater than 200.
Population snapshots
For the country- based, species- wide analysis, fastq reads from 
each isolate were mapped using BWA against a complete S. 
pneumoniae genome ATCC 700669 (NCBI accession code 
FM211187) [19]. The pseudo- genome alignment was then 
reduced to variant sites using SNP- sites for phylogenetic tree 
construction using FastTree2 [24, 25]. The SNPs were then 
reconstructed on the tree [26, 27]. Country- based analysis 
was only performed on the countries with isolates >100 
(n=12, Table 1).
External datasets
We included an externally sequenced dataset that was not 
included in the PopPUNK definition of GPSCs to demonstrate 
that GPSCs can be assigned to any pneumococcal genome. 
Seventeen serotype 1 isolates collected from children with 
invasive disease from Utah, USA between 1996 and 2011 were 
included. Among them, metadata was available for 14 isolates, 
of which 13 were associated with complicated pneumonia 
with empyema. They were whole- genome sequenced on an 
Illumina HiSeq 2500 platform with 125 bp paired- end reads 
at the Huntsman Cancer Institute at the University of Utah. 
The data was imported and assembled as previously described 
[16]. Assemblies were submitted to Pathogenwatch, which 
assigns pneumococcal serotypes using SeroBA, and GPSCs 
using PopPUNK and the GPS reference database [3, 4, 28, 29]. 
Raw data and assemblies were deposited in the ENA under 
the study accession PRJEB34550. The isolates from Utah were 
also mapped to the GPSC31 reference (GenBank accession 
GCA_901234765) and combined with GPS GPSC31 strains 
to produce an alignment. Recombiantion was masked with 
Gubbins to build a phylogenetic representation of the external 
data and GPSC31 [9].
RESUltS anD IntERPREtatIOn
assessing temporal signal in pneumococcal GPSCs
The BactDating models of temporal phylogenetic signal 
that had converged, were significantly better than the 
randomized dates model, and had effective population 
sizes of greater than 200, represented 70 % (51/73) of the 
GPSCs analysed. For the remaining GPSCs, 6/22 did not 
converge, 11/22 were no better than the randomized dates 
model, and for 5/22 the effective population sizes were <200 
(Supplementary Material Fig. S1). Previously we reported 
recombination/mutation ratios for the GPSCs and calcu-
lated recombination- free pairwise SNP distances for the top 
30 GPSCs [3]. We did not observe any extreme values for 
these metrics in the GPSCs we were unable to date, except 
smaller sample sizes and a lack of temporal signal.
The estimated dates across the lineages were somewhat 
consistent, with the average most recent common ancestor 
(MRCA) for the 51 GPSCs being 1814 [1640–1897] (Fig. 1). 
Large diverse lineages with strong sub- structure become 
prohibitively computationally intensive for dating using beast, 
comparing the most recent common ancestor for the four sub- 
clades CC53, CC62, CC100, CC1012 of GPSC3 from beast and 
BactDating revealed similar estimates (Table 2).
In general the GPSC dates are older but not inconsistent 
with previous reports of pneumococcal clones, which often 
represent sub- clades of GPSCs and where the definition 
of clone, sampling and geographical representation may 
not have been as extensive [30–32]. PMEN1 a sub- clade of 
GPSC16, was previously estimated to have shared a common 
ancestor in 1969 [1958–1977], the BactDating estimate of 
the MRCA of PMEN1 (ST81) isolates was identical 1969 
[1958–1977] [14]. PMEN2 is a sub- clade of GPSC23 and 
was previously estimated to be of Western European origin 
between 1962 and 1974, the BactDating estimate of the 
MRCA of the PMEN2 (ST90) isolates of 1977 [1968–1983] 
overlaps with that estimate [31]. PMEN14 a sub- clade of 
GPSC1 was previously estimated to have shared a common 
ancestor in 1987 [1981–1991], the BactDating estimate of 
the MRCA of PMEN14 (ST236) isolates was much older 
and less certain 1885 [1807–1929]. Even when excluding 
the two most basal isolates of ST236 the estimate of 1949 
[1904–1968] does not overlap with the previous estimate 
[6].
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Fig. 1. Point estimates of the year of the most recent common ancestor (MRCA) of each of the 51 GPSCs that could be reliably estimated. 
The 95 % confidence intervals (CI) are plotted.
Table 2. Comparison of key feasible beast runs and BactDating models of phylogenetic dating
Lineage sub- clade Year range N beast tMRCA BactDating tMRCA
GPSC3 18 358 Run infeasible 1720.54 [1634.01–1780.92]
GPSC3- CC53 12 152 1879 [1820.49–1921.87] 1926.77 [1907.99–1941.56]
GPSC3- CC62 17 56 1912.82 [1667.10–1967.00] 1929.64 [1908.24–1944.03]
GPSC3- CC100 17 67 1937.13 [1920.19–1950.82] 1919.82 [1899.11–1936.45]
GPSC3- CC1012 17 83 1878 [1808.91–1925.02] 1840.70 [1802.97–1870.36]
CC, Clonal Complex; GPSC, Global Pneumococcal Sequence Cluster; tMRCA, Time to Most Recent Common Ancestor.
The conserved range of dates across GPSCs could result 
from two processes: (1) clones emerge and die at a roughly 
constant rate, meaning there is an underlying exponential 
distribution of ages; (2) a clone needs to be old enough to 
have to be measurably evolving and established enough to be 
well sampled, preventing younger clones from being dated. 
Many of these GPSCs represent globally spread clones, the 
period of human history from 1600 to 1800 is known as 
the proto- globalisation era, with large scale globalization 
beginning in the 1820s [33, 34]. This would have included 
the migration of families with children who may have been 
colonized with the pneumococcus, providing a new oppor-
tunity for global spread of local strains.
Defining the pangenome
In 13 454 genomes, only 634 and 868 genes met the core 
gene definition of present in >=99 % or >=95 % of the collec-
tion respectively when paralogues were spilt. This is likely 
an underestimate as mis- assemblies, contig breaks and 
missing annotations can erode the number of genes that 
meet these criteria. The resultant core gene alignment was 
544 759 bp long with 147 832 variable sites. A further 1957 
genes were classified as shell genes (>=15 to <95 %) and 
24 219 as cloud genes (>=1 to <15 %). The average number of 
genes defined as core (>=95 %) within lineages (GPSCs) was 
1276. The mean core gene number per GPSC was higher 
than in the total collection in part because genes that are 
accessory to the species can be common to all isolates of a 
lineage, and because fewer genes will have been misclassi-
fied as non- core due to an accumulation of assembly and 
annotation errors.
Example 1a: Exploring country phylogenetic 
snapshots using microreact
A phylogenetic snapshot of the population diversity in a single 
country can be clearly visualized interactively in Microreact. 
The interface is user- friendly and easy to filter on particular 
features (e.g. serotype), manifestation (carriage or disease), 
and/or demographic data (e.g. age). The South African 
population snapshot represents two cross- sectional coloni-
zation studies and national IPD surveillance surrounding 
PCV introductions. Such a dataset allows exploration of the 
population structure to contextualize numerous scenarios, for 
example it clearly highlights the diverse genetic background 
of serotype 14 isolates (Fig. 2a) [35]. The 278 South African 
isolates expressing serotype 14 in this collection were found 
within nine unrelated GPSCs – they do not share a common 
ancestor. Overall, 22 % (61/278) of serotype 14 isolates from 
South Africa were found in GPSC9 (61/67). They exclusively 
belonged to clonal complex (CC)63, and 38/61 (63 %) were 
ST63. However, there appeared to be phylogenetic structure 
within GPSC9/CC63/ST63 (Fig. 2a, b).
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Fig. 2. Contextualizing serotype 14 genotypes in South Africa. (a) Phylogeny of South African pneumococcal population structure, with 
taxa expressing serotype 14 highlighted by a coloured circle representing their GPSC assignment, GPSC9 (blue) is highlighted with a box. 
(b) Expanded South African GPSC9 subtree where taxa are coloured by serotype: 14 (blue) and 15A (yellow). The left metadata block is 
coloured by clonal complex: CC63 (pink), CC12576 (green). The right- hand metadata block is coloured by sequence type: ST63 (green), 
ST2414 (orange). Three sub- clades (A,B,C) that each contain at least one ST63 isolates are highlighted with a box. (c) The international 
GPSC9 collection have taxa coloured by country of isolation with a map based key, the three South African (purple) sub- clades (A,B,C) 
are highlighted in the international GPSC9 collection with a labelled box.
Example 1b. Placing observations in the 
international context of a GPSC using microreact
The context of the international GPSC9 phylogeny revealed 
three sub- clades in South Africa’s sample of GPSC9 serotype 
14 ST63. Each sub- clade shared a common ancestor with 
isolates from other geographical regions before they share 
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Fig. 3.  GPSC97 capsular polysaccharide locus recombination events. Phandango plot of recombination detected with Gubbins, focused 
on the cps locus, across the GPSC97 phylogeny. Isoaltes are annotated with their serotype in a metablock: 6A (pink) 19A (blue). 
Recombination blocks span the taxa in which they are detected and the region of genes affected in the reference. Red blocks affect n>1, 
blue blocks affect n=1. Overlapping blocks increase the density of the colour. A sliding window of the number of recombination events 
affecting any one position in the reference is plotted at the underneath. The major recombination block spanning most of the cps locus 
and common to all 19A isolates is consistent with the serotype switch, and is outlined in blue. The nodes for most recent common 
ancestors of the 6A and 19A isolates and the 19A isolates are designated with a blue circle, estimated dates and confidence intervals 
are given.
a common ancestor, suggesting they are not of shared South 
African descent (Fig. 2c). Using the dated GPSC9 phylogeny 
we can infer that the South African isolates represent three 
independently successful sub- clades established around 
the 1980s (A 1985[1976–1992], B 1995[1987–1999], C 
1985[1978–1990]) and shared a common ancestor in the first 
half of the twentieth century 1933 [1909–1951].
Example 2: Relating recombination events to 
changes in phenotype using Phandango
Recombination is known to facilitate clinically relevant 
changes in phenotype such as serotype switch. GPSC97 
(CC1339/CC376), only observed in the USA in this collec-
tion, expressed either serotype 6A (13/23, 57 %) or 19A 
(10/23, 43 %). ST1339 was first reported expressing 6A and 
19A in pubMLST in 2002 and 2006, respectively, in the USA. 
The earliest isolation date of 6A and 19A within GPSC97 in 
this collection was 1998 and 1999, respectively. There was 
phylogenetic structure to the serotypes expressed, and ances-
tral reconstruction of serotype suggests the clone originally 
expressed 6A. Visual inspection of recombination blocks in 
GPSC97 across the genome allowed the identification of a 
20 495 bp recombination event spanning capsular polysaccha-
ride locus (cps) genes wzh to aliA, which coincided with the 
change in serotype (Fig. 3). There was evidence of four other 
shorter recombination events affecting 1–12 isolates in the cps 
locus, which did not result in a change in serotype (Fig. 3). 
The date for the most recent common ancestor (MRCA) of 
the 19A strains was estimated to be 1997 [1995–1998], the 
MRCA for the 19A strains and the 6A strains was estimated 
to be 1995 [1990–1997] therefore the recombination event 
likely occurred between 1990 and 1998. This recombination 
event did not extend out to pbp2X and therefore had no affect 
on penicillin susceptibility. It was previously determined that 
all of GPSC97 had an identical pbp2X allele, and a predicted 
MIC of >=2 µg l−1 [3].
Example 3: Detecting antibiotic gene acquisition 
associated with mobile genetic elements using 
Phandango
Recombination and integration of mobile genetic elements 
(MGEs) can result in the acquisition of multiple accessory 
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Fig. 4. GPSC23 acquired resistance gene presence and absence. Phandango plot of Roary gene presence and absence, focused on the 
genes with prevalence and phylogenetic patterns similar to acquired resistance genes: tetM 61 %(110/180) ermB 43 %(77/180) and cat 
40 %(72/180), across the GPSC23 phylogeny. Isolates are annotated with their serotype in a metablock: 6B (green), 6A (pink) and 19A 
(blue). Genes are shown as light blue bricks along the top and are sorted left to right by the proportion of isolates they are observed in. 
Presence (blue) and absence (white) of genes is plotted with respect to each isolates phylogenetic placement. A graph of the proportion 
of isolates the gene is observed in is plotted at the underneath.
Table 3. Pathogenwatch output
Summary
No. assemblies processed 17
No. analyses performed 102
Time taken 3 min
No. contigs 38–58
GC content 39.5–39.6 %
Assembly length 2.04–2.14 Mb
Species Streptococcus pneumoniae (100 %, 17/17)
Serotype 1 (100 %, 17/17)
ST ST227 (59 %, 10/17)
ST306 (24 %, 4/17)
ST304 (12 %, 2/17)
ST4288 (6 %, 1/17)
Strain GPSC31 (100 %, 17/17)
AMR determinants None identified
AMR, Antimicrobial resistance; Mb, Megabases.
genes in a single event, for example multiple acquired resist-
ance genes can be carried by a single MGE. Members of 
GPSC23 (CC273) were commonly (106/180, 59 %) predicted 
to be multidrug resistant (>=3 classes). This lineage is globally 
disseminated; observed in 13 countries representing Africa, 
Asia, Europe, North and South America. GPSC23 encom-
passes multiple Pneumococcal Molecular Epidemiology 
Network (PMEN) multidrug- resistant (MDR) clones: PMEN2 
Spain6B (ST90), PMEN17 Maryland6B (ST384) and PMEN22 
Greece6B (ST273). This provides further confirmation on the 
relatedness of PMEN2 and PMEN22 reported previously [31]. 
Altogether, 33 % (59/180) of GPSC23 have the acquired resist-
ance genes cat, ermB/mefA and tetM conferring resistance to 
chloramphenicol, erythromycin and tetracycline, respectively. 
The phylogenetic structure to the presence and absence of 
these genes in GPSC23 is variable (Fig. 4). The 58/59 isolates 
that carry cat, ermB and tetM fall in a sub- clade of 87 isolates 
encompassing PMEN2 and PMEN22. There appeared to be 
stable maintenance of tetM n=87/87, two independent losses 
of ermB n=76/87 and multiple independent losses of the cat 
gene n=58/87. Genes that are present in a similar propor-
tion of isolates and similar phylogenetic pattern to these 
acquired resistance genes include those annotated as Tn916, 
Tn5253 and Tn5252 indicative of a composite transposon 
with gene loss since its integration (Fig. 4). Such variation 
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Fig. 5. Giving context to serotype 1 isolates from Utah. (a) Different geographical distribution of serotype 1 genomes belonging to GPSC2 
and GPSC31 on Pathogenwatch. (b) Serotype 1 isolates in the GPS project (n=893/13,454) fall exclusively into two lineages (green): 
GPSC2 (n=782) and GPSC31 (n=111), which are in different parts of the species- wide tree and do not share a recent common ancestor. 
(c) Utah isolates are highlighted on a and coloured by their ST (see key), the metablock shows the country of isolation across the GPC31 
tree structure, and USA state on the expanded subtree. Triangle A denotes the most recent common ancestor 1973 [1958-1981] of the 
USA sub- clade in which the majority (10/17) of the Utah serotype 1 isolates were found.
is often difficult to assemble with short read data, the gene 
presence absence plot suggests a composite Tn916- Tn5253 
element accounts for most of the acquired resistance genes in 
this lineage. Using the dated tree for GPSC23 we estimate the 
date of acquisition to be around 1966 [1953–1975]. This fits 
all with previous work reporting inactivation or loss of resist-
ance genes from a composite Tn5253- type integrative and 
conjugative element in PMEN2 in a similar timeframe [31].
Example 4a: Contextualizing other datasets using 
the GPSCs and Pathogenwatch
Raw reads or assemblies can be dragged and dropped onto 
Pathogenwatch, which will QC the assemblies and check if 
they belong to the pneumococcus. Then it will assign their 
multi- locus ST, GPSC, serotype and report the detection of 
key genetic determinants of antimicrobial resistance (AMR). 
The assemblies from 17 serotype 1 isolates from Utah, which 
are external to the dataset used to define the GPSCs, were 
assigned by Pathogenwatch to GPSC31 (Table 3).
The assignment of GPSCs to these isolates allows them to be 
put in a global context. All 20 027 pneumococcal genomes 
previously used to define the GPSCs are deposited in the 
Pathogenwatch [3]. Serotype 1 isolates in Pathogenwatch are 
only found in two lineages: GPSC2 and GPSC31, the database 
can be filtered on metadata, for example by strain (GPSC) and 
serotype, to view the geographical distribution, which differs 
between the two GPSCs (Fig. 5a). Differential geographical 
distributions of serotype 1 clones has been previously reported 
in the literature [36, 37]. Indeed within the GPS collection 
GPSC2 alone accounted for all the serotype 1 isolates from 
South Africa, Malawi and The Gambia, whilst GPSC31 was 
more common than GPSC2 in Israel and the USA, consistent 
with finding the Utah isolates only in GPSC31 [3].
These two lineages only express serotype 1 but do not share 
a recent ancestor in the species- wide tree (Fig. 5b). GPSC2 is 
composed of clonal complexes CC217, CC3581 and CC615, 
whilst GPSC31 includes CC5784, CC306 and ST227. ST227 
was the predominant ST seen in children with pneumococcal 
empyema in Utah before conjugate vaccine introduction [38]. 
The relationship between these clones using genome- wide 
variation is consistent with previous designations of lineages 
A, B and C inferred from MLST where A represents GPSC31 
and B and C are sub- clades of GPSC2 [36]. The tMRCA of the 
GPSC2 was estimated as 1655 [1230–1818] and for GPSC31 
1814 [1702–1882], suggesting the serotype 1 CPS was trans-
ferred into a second lineage before the twentieth century.
The clones of serotype 1 have also been associated with 
different manifestations of disease, with lineage A (GPSC31) 
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associated with pneumonia with or without empyema in 
Europe and North America and lineage B/C (GPSC2) with 
bacteremia and meningitis in Africa [37, 39, 40]. In Utah sero-
type 1 disease has been associated with pleural empyema and 
the STs of GPSC31 [38]. Serotype 1, 100 % ST 227, was identi-
fied in 50 % of children with empyema in Utah in the decade 
before the licensing of pneumococcal conjugate vaccine [41]. 
Serotype 1 was identified in 33 % of children with empyema 
after PCV7 introduction [38] but was relatively rare in other 
USA populations. Finally the absence of AMR determinants 
(Table 3) in the Utah isolates is typical of serotype 1, 72 % of 
GPSC2 and 99 % of GPSC31 were previously predicted to be 
pan- susceptible to the five antibiotics tested [3].
Example 4b: Contextualizing additional data within 
a GPSC
After mapping the Utah isolates to the GPSC31 reference 
(GenBank accession GCA_901234765) and masking recom-
bination using Gubbins we observed that 10/17 of the Utah 
isolates fell into a GPSC31 sub-clade of 28 isolates that were 
only isolated in the USA (Fig. 5c). These ten Utah isolates were 
spread across this sub- clade but GPS USA isolates were basal, 
this sub- clade in the dated GPSC31 tree shared a MRCA in 
1962 [1941–1975]. The remaining seven isolates clustered in 
two other regions of the tree, which had broader geographical 
representation (Fig. 5c).
DISCUSSIOn
Large- scale bacterial genomic data generation is increas-
ingly common in the next- generation sequencing era. The 
availability of raw data, assemblies and annotation currently 
deposited in the European nucleotide archive (ENA) are an 
invaluable open data resource with huge potential for research 
beyond the original research scope, especially if paired with 
metadata. However, visualizing results in an interactive tool 
can make the data vastly more accessible than the availability 
of primary data files [1, 2]. Constructing a bioinformatic 
workflow involving genotyping, identifying recombination 
and robustly building and dating phylogenies, is a special-
ized activity requiring resources and training. Automated 
genotyping from raw reads or assemblies combined with 
databases of genomes vastly increases accessibility, and the 
utility of private sequencing data in the context of public data 
processed in a standardized manner. Furthermore, interactive 
phylogenies of published data combined with metadata allows 
those who have yet to harness such bioinformatic skills to 
explore the output of genomic analyses and gain experience 
of its uses and interpretation.
Nonetheless, for those with sufficient bioinformatic experi-
ence, the interactive element is far superior to static figures 
and is invaluable for exploring the data to test and generate 
hypotheses. The interactive data that we present here, does 
still require knowledge of how to interpret phylogenetic 
trees and the limitations of bioinformatic methods. The tool 
Roary allows the rapid determination of pan genomes in large 
datasets from annotated assemblies. It relies on user- defined 
percentage identity thresholds, unsupervised algorithms for 
defining a gene, and assembly errors can lead to underestima-
tion of core genes and a likely overestimation of singleton 
genes [17]. Gubbins readily identifies differences in SNP 
densities across the genome between isolates of the same 
lineage as recombination [9]. It relies on robust definitions 
of a lineage such as GPSCs, but is limited in its detection of 
recombination that does not result in a sufficient difference 
in SNP density, such as recombination within highly similar 
strains [9]. It does allow the identification of SNP dense 
recombination events that alter important phenotypes as we 
demonstrate here for serotype. Phandango allows such recom-
bination data to be displayed interactively across the genome 
making recombination hotspots readily visible. Phylogenetic 
reconstruction relies on the vertical accumulation of varia-
tion, and therefore the identification of recombination and 
masking from lineage alignments is important. Many models 
currently exist that infer phylogenies with different advantages 
and disadvantages but all rely on the quality of the alignment 
[42]. Phylogenetic dating also depends on robust masking of 
recombination, the subsequent phylogeny, as well as sufficient 
temporal sampling and the presence of temporal signal. Dated 
trees allow us to add a temporal context to other observations 
such as capsular switch events, geographical dissemination 
and gene acquisition.
Resource maintenance
Here we present phylogenetic analyses for 73 lineages and 12 
countries, those that had reasonable sample numbers for such 
analyses. As the the GPS collection grows it will be possible to 
perform the analyses on further lineages and country popu-
lation snapshots. Any resulting Microreact or phandango 
instances will be created and made accessible via the resources 
tab of the www. pneumogen. net/ gps/. Adding further samples 
into existing phylogenies with ease and without repeating 
significant analyses is an area in which further bioinformatic 
development is needed. The definition of GPSCs will be 
updated, to include novel clusters as more sequence data is 
generated including those from external data if provided via 
www. pneumogen. net/ gps/. Subsequent versions will be made 
available at www. pneumogen. net/ gps/ assigningGPSCs. html 
and incorporated into Pathogenwatch.
Microreact and Pathogenwatch are developed and maintained 
by the Centre for Genomic Surveillance (CGPS) at the Big 
Data Institute, University of Oxford and Wellcome Genome 
Campus, Hinxton, UK (http:// pathogensurveillance. net). 
The underlying methods and software used to genotype rely 
on robust established schemes and databases, or bespoke 
pipelines and emerging software, with the latter two under 
continuous review and development to improve accuracy and 
reproducibly. CGPS have made comprehensive documenta-
tion available here: https:// cgps. gitbook. io/ pathogenwatch/. 
Those who wish to make use of Pathogenwatch to genotype 
their data (e.g. example 4a), or to visualize phylogenies 
representing their own data and metadata, with or without 
combining with GPS data in Microreact (e.g. example 4b) can 
do so privately by logging in. Any uploaded sequence data, 
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phylogeny or associated metadata is not made available to 
other users or collaborators, or used in the internal analyses 
of the centre for Genomic Surveillence, without explicit 
consent. The Phandango website processes data ‘dragged and 
dropped’ in the users web browser with no data leaving the 
user's computer.
We show that the GPS collection of interactive results, dated 
phylogenies and GPSC definitions give useful insights for 
common research questions in the study of pneumococcus. 
This applies to exploring the GPS collection or external data. 
The data however also have use beyond the pneumococcal 
community, as a teaching resource, or for mathematical 
modelling of features relevant to other pathogens, to under-
stand the evolution of antimicrobial resistance, geo- temporal 
spread of clones and the phylogenetic histories of populations.
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